Literature DB >> 18510541

Haemophilia in the first years of life.

R Ljung1, H Chambost, A-M Stain, D DiMichele.   

Abstract

Surgery in infants and young children with haemophilia, when preceded by accurate diagnosis and accompanied by safe and effective factor prophylaxis, is not associated with a significant risk of haemorrhage. Haemophilic newborns undergoing circumcision or major surgery prior to diagnosis and in the absence of appropriate haemostatic prophylaxis remain as a concern. Inhibitor development has replaced haemorrhage as the major surgical complication in the developed world, largely because of the intensity of treatment used to secure haemostasis. For that reason only, essential surgery should be performed. Intracranial haemorrhage (ICH) during the neonatal period affects 3.5-4.0% of all haemophilia boys in countries with a good standard of health care, which is considerably (40-80 times) higher than expected in the normal population. Because of the high frequency of sporadic cases, ICH in the neonatal period can only be partially prevented by improved carrier diagnosis and counselling. Infections and thrombosis are the major serious complications of central venous lines. Large differences are seen in the frequency of these complications, the most plausible explanations are probably related to the protocol used for device care, the quality of education and the compliance of the users, an issue addressed in an on-going study.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18510541     DOI: 10.1111/j.1365-2516.2008.01722.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  6 in total

1.  Design of the INHIBIT trial: preventing inhibitors by avoiding 'danger', prolonging half-life and promoting tolerance.

Authors:  Margaret V Ragni; Lynn M Malec
Journal:  Expert Rev Hematol       Date:  2014-11-05       Impact factor: 2.929

2.  Recombinant factor VIII in the management of hemophilia A: current use and future promise.

Authors:  Jerry S Powell
Journal:  Ther Clin Risk Manag       Date:  2009-05-20       Impact factor: 2.423

3.  Haemophilia at various stages of life: design of new therapeutic strategies through an interactive course--the Kogeniale project.

Authors:  Elena Santagostino; Maria Messina; Annarita Tagliaferri; Alfonso Iorio; Massimo Morfini
Journal:  Blood Transfus       Date:  2013-01-23       Impact factor: 3.443

Review 4.  The existing scenario of haemophilia care in Canada and China - A review.

Authors:  Rohan Pratap; Monali Misra; Varun N; Suman Morampudi; Anand Patil; Jayachandra Reddy
Journal:  Hematol Transfus Cell Ther       Date:  2019-10-27

5.  Circumcision in males with bleeding disorders.

Authors:  Hassan Mansouritorghabeh; Abdollah Banihashem; Alireza Modaresi; Lida Manavifar
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-01-02       Impact factor: 2.576

6.  Neonatal Hemophilia: A Rare Presentation.

Authors:  Nuno Ferreira; Elisa Proença; Cristina Godinho; Dulce Oliveira; Ana Guedes; Sara Morais; Carmen Carvalho
Journal:  Pediatr Rep       Date:  2015-12-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.